- 부서명 : 기획조정과
- 작성일 : 2021-05-14
- 조회수 : 71
- 출처: 유럽의약품기구(EMA)
EMA is implementing additional temporary measures to further streamline activities in the
European medicines regulatory network to enable experts to deal with an increasing volume
of COVID-19-related assessment procedures.
Due to the very active pipeline of upcoming COVID-19 vaccines and treatments, a number of
ongoing procedures, and the roll-out of authorised vaccines to millions of people across the EU,
the resources of EMA and the European medicines regulatory network are highly focused on
the review of COVID-19 vaccines and therapeutics, and the rigorous safety monitoring of these medicines
☞ 자세한 사항은 내용바로가기를 통해 확인하실 수 있습니다.